Date:2021-09-06
By:Zhong Yuan Biotech
In the morning of July 3rd, 2019, at the Occupational Safety and Health Research Center of the National Health Commission, Baofeng Biotech(Beijing) Co., Ltd. joined hands with the Occupational Safety and Health Research Center of the National Health Commission to hold the opening ceremony of "key Laboratory of genetic Metabolism Research (Co-Construction)". Leaders of the Occupational Health Center, representatives of both sides, such as Baofeng Biological CEO Chang Tingting and CTO Dr. Chen Xianyang, as well as media workers jointly participated in the ceremony.
The laboratory was also officially launched on the same day, and will gradually carry out blood concentration detection and multi-level integrated analysis of cardiovascular, endocrine, thoracic, urology, neurosurgery and neurosurgery to complete the accurate diagnosis of genetic metabolic diseases.
Secondly, the laboratory will also be based on the development of clinical testing of nervonic acids and increase the sample size to complete the screening of early screening markers for AD (Alzheimer's disease), PD (Parkinson's disease) and MS (multiple sclerosis). In addition, the laboratory will, adhering to the purpose of the Occupational Safety and Health Research Center of the National Health Commission "serving the government, enterprises and society", make every effort to do a good job in the research on the prevention and control of occupational diseases of the nervous system and the technical services of occupational health, to make greater contributions for production safety and occupational safety and health.
The Occupational Safety and Health Research Center of the National Health Commission was formerly known as the Institute of Occupational Medicine of the Ministry of Coal Industry. The original purpose of the institute was to perform better in the prevention and control of occupational health and occupational diseases in the national coal system. After 30 years of development, it has become a public welfare scientific research institution integrating occupational disease prevention research, medical treatment, teaching and occupational health technical services, and has an important influence in the field of occupational safety and health. It is an institution directly under the National Health Commission. Director Zhang of the Center first affirmed the professional strength of Baofeng Biotechnology (Beijing) Co., Ltd. in nervonic acid extraction, research and development and nervous system metabolism research, and said that he would give full play to the professional advantages of occupational disease prevention and control research and technical services and work hand in hand with Baofeng Biotech to promote the progress and development of human health.
BaoFeng Biotech, as a biotechnology company specializing in the research, development, production, sales and technical services of Acer truncatum nervonic acid and related brain health products, is also the chairman of the technological Innovation Strategic Alliance of China's woody oil industry. Since its establishment 7 years ago, it has made outstanding contributions to human brain health. The founder, Ms. Chang Tingting, briefed the guests on the basic development of the company, the vision of leading the development of the nervous acid industry, and the mission of applying and developing the medical value of nervous acid. In the near future, relying on the platform and technical resources provided by the Occupational Safety and Health Research Center of the National Health Commission, the extraction and application of Baofeng's nervonic acid will be further developed, bringing an epoch-making scientific and technological revolution to human brain health.
Chen Xianyang, CTO of Baofeng Biology and Doctor of Developmental Biology of the Chinese Academy of Sciences, believes that the cooperation with the Occupational Safety and Health Research Center of the National Health Commission will be more in-depth. Nervonic acid is an important lipid marker of Alzheimer's disease. In the future, biochemical indicators will be constructed to predict and evaluate Alzheimer's disease. In addition, Baofeng will also be involved in the field of genetic metabolic diseases and nervous system occupational diseases, which are serious threats of human survival, and challenge this major public health issue of great concern to countries all over the world. Over the past five years, Baofeng biotech has successfully extracted nervonic acid from the fruit of Acer truncatum through painstaking research; and according to the preliminary clinical results, a series of products have been developed for different groups of people, such as: Wood-derived brain power nervonic acid oil, wood-derived plateau companion, wood-derived Acer truncatum maple formula oil, and Acer truncatum seed oil - nervonic acid candy, which is aimed at teenagers, urban white collars and the elderly who are in urgent need of maintenance.
This is just the beginning for both parties. In the future, parties will focus more on the landing work such as the transformation of scientific research achievements, the research on engineering protection technology for key occupational disease hazard factors, the cooperation and docking of hospital projects, and the provision of comprehensive medical services for rehabilitation and recuperation. Co-created laboratory will serve the people, and actively promote the development of screening, diagnosis, treatment, intervention and rescue of genetic metabolic diseases and nervous system occupational diseases, and establish norms for multi-disease screening.